STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Source
Stat News
Opens original article in a new tab

(MedPage Today) -- President Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs of up to 100% on some patented drugs from companies that don't reach deals with his administration in the coming months...

Congress largely ignored President Trump's previous budget proposal, instead boosting federal health spending.

(MedPage Today) -- A short course of darolutamide (Nubeqa) enhanced the imaging signal of prostate-specific membrane antigen (PSMA)-PET in a subset of patients with high-risk localized prostate cancer, according to findings from the phase II Daro...

(MedPage Today) -- Red blood cell exchange transfusion (ET) reduced the risk of in-hospital death and 30-day readmission in patients with severe cases of the tick-borne disease babesiosis, according to a target trial emulation using data from a...